Tumor suppression was observed when treating S-180 tumor-bearing mice with MPEG–PCL-SS-Tat/si VEGF complexes compared with naked siVEGF and MPEG–PCL-SS-Tat/si control treatment. This evidence concerns the gene TAT and neoplasm.